Background--The incidence of hypertensive emergency in US emergency departments (ED) is not well established.
H ypertensive emergencies are defined by marked blood pressure (BP) elevations (typically >180 mm Hg systolic or >110 mm Hg diastolic, though this cutoff is arbitrary) that are associated with acute target organ damage. [1] [2] [3] [4] Target organs typically involved include those in the cardiovascular, renal, or central nervous systems. 5, 6 While not all patients with markedly elevated BP have a hypertensive emergency, initiation of appropriate treatment for those who do is critical as delays are associated with significant morbidity and mortality. 7 However, caution is warranted as patients with chronically elevated BP have a rightward shift in cerebral blood flow autoregulation, placing them at risk of stroke and myocardial infarction when BP is lowered too rapidly. Despite the importance of hypertensive emergency, the burden of this condition is not known, and there are conflicting views of the epidemiology in academic literature. Prior empirical evidence from claims data suggests that the annual hospitalization rate for hypertensive emergencies is 1 or 2 per million. 8 Data from the Nationwide Inpatient Sample, a multicenter database developed as part of the Agency for Healthcare Research and Quality's Healthcare Cost and Utilization Project to track hospital discharges, analyzed in the wake of the Seventh Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure, 9 place this figure higher, reporting an annual frequency of hospitalizations for a hypertensive emergency in US adults of 101 per 100 000 in 2000 and 111 per 100 000 in 2007. 10 While important, these data exclude information on the emergency department (ED) phase of patient care and provide little insight into the relative volume of patients who present to EDs with a hypertensive emergency. At present, the only existing comprehensive epidemiological data related to this come from 1 study of a Brazilian population, where hypertensive emergencies were found to be present in 0.3% of all ED visits. 11 Despite the limited empirical evidence, there are claims in the literature that hypertensive emergencies make up as much as one fourth of all ED visits, 12 orders of magnitude more than existing estimates. Such uncertainty about the incidence of hypertensive emergencies occurs in the context of a significant and growing perspective that hypertension is a public health problem. 13, 14 One study found that hypertension-related hospitalizations increased by more than 27% in the period from 2000 to 2011. 15 Hypertensionrelated ED visits increased in the period from 2006 to 2012 by an estimated 5.2% per year, from 20.5% to 25.7%. 16 From both epidemiological and clinical perspectives, more information on the ED burden of hypertensive emergencies would be of great value.
Goals of This Investigation
The goal of this investigation is to characterize the incidence of hypertensive emergency in EDs nationwide in the period from 2006 through 2013. 
Materials and Methods

Data Analysis
The analyses for this study were performed according to recommendations from the Agency for Healthcare Research and Quality for weighting and stratification. All values reported are weighted to be nationally representative. Yearly incidence rates were calculated for the criteria defining hypertensive emergency, including subgroup analyses for each type of target organ damage (eye, heart, blood vessel, and brain). The proportions of ED visits for hypertensive emergency were calculated separately with denominator of all ED visits, ED visits resulting in admission, and hypertensionrelated ED visits (401.x-405.x, 437.2). Patient and hospitallevel characteristics were compiled among ED visits with hypertensive emergency. Variables summarized for those visits qualifying as hypertensive emergencies are the following: ED disposition, hospital disposition (for those patients who were admitted to the same hospital where they presented to the ED), ED charges (by quartile), primary payer (Medicare, Medicaid, private insurance, self-pay, and no charge), hospital length of stay in days (by quartile), age in years (by quartile, where all ages over 89 are placed into a single category), percent female, and median household income in patient's home zip code (by percent in each income quartile). A logistic regression model was performed to estimate the unadjusted annual change in incidence rates for hypertensive emergency ED visits, taking into account the complex sampling design, including weighting and stratification, of the sample. An additional logistic regression model was also performed, which included adjustment for primary payer, income quartile of the patient's zip code, age, and sex. All analyses were conducted in SAS 9.4 (SAS Institute, Cary, NC).
Results
Main Results
Figure 1 depicts how the study population was derived, and from that sample, how hypertensive emergency was defined. Figure 2 shows the trend in absolute number of ED visits for acute hypertension, acute hypertension with qualifying disposition (admission, death in ED, transfer to another hospital), acute hypertension with target organ damage, and hypertensive emergency (all 3 criteria). As depicted in Figure 2 There was a similar increase in the number of ED visits for acute hypertension that also carried a diagnosis for acute target organ damage, from 65 925 (95% CI 59 872-71 966) to 188 696 (95% CI 170 284-207 082), and in the number of ED visits for acute hypertension that also carried a qualifying disposition (admission, death in ED, or transfer to another facility), from 63 406 (95% CI 57 297-69 584) to 398 506 (95% CI 356 724-440 243). Among diagnoses for acute target organ damage, heart failure was the most common, present in 117 848 hypertensive emergencies in 2013. The second most common diagnosis was cerebrovascular disease or stroke, with 51 062 visits in 2013. Papilledema and retinal hemorrhage associated with increased intracranial pressure were relatively rare, with only 194 total hypertensive emergencies in 2013 carrying these ICD-9 CM diagnosis codes.
Total hypertensive emergencies by our definition increased by 16 .2% per year from 2006 to 2013, while the overall number of ED visits in that same period increased at an average rate of 2.0% year-over-year. Despite such a large increase, in terms of the rate per million adult ED visits, hypertensive emergencies remained a rare diagnosis, with an incidence of 677 per million adult ED visits in 2006 and 1640 per million adult ED visits in 2013, yielding an estimated rate increase of 13.9% per year (P<0.0001). This year-over-year change in the incidence of hypertensive emergency remained statistically significant (P<0.0001) even after adjustment for payer, income, age, and sex. In these estimates, the denominator is total number of adult ED visits, and this should not be interpreted as the raw number of ED visits for hypertensive emergency, which were given above. Table 1 summarizes these results and the distribution of diagnoses for target organ damage associated with hypertensive emergency, from 2006 through 2013. Table 2 depicts hypertensive emergency rate per million with varying denominator: among all ED visits, among ED visits resulting in admission, and among ED visits with any diagnosis of hypertension. Table 3 depicts demographic information about patients with hypertensive emergency from 2006 through 2013. For 2013, 4.5% of ED visits qualifying as hypertensive emergency resulted in patient's death, either in ED or during the following hospital admission. The mortality rate was 4.8% in 2006, for an absolute decrease in total mortality rate of 0.3%, though this change was not monotonic year-over-year. Visits for hypertensive emergency tended to occur in older patients (median age was 66 years in 2013) who were slightly more likely to be female (54.5% in 2013). In addition, a sizeable proportion (39.7%) of hypertensive emergency ED visits were from patients who lived in zip codes with average income in the bottom quartile. Overall, 63.0% of ED visits for hypertensive emergency had primary payer as Medicare, 10.7% had Medicaid, and another 7.9% were categorized as self-pay in 2012. Median total ED charges among visits for hypertensive emergency rose monotonically from $956 in 2006 to $1800 in 2013.
Characteristics of ED Visits
Discussion
Our primary finding is that ED visits for hypertensive emergency, that is, ED visits for patients who have markedly elevated BP with acute target organ damage and an acuity level high enough to necessitate hospital admission, are quite rare, accounting for less than 2 in 1000 adult ED visits and 6 in 1000 visits carrying any diagnosis of hypertension in 2013.
Thus, while markedly elevated BP at presentation to the ED is quite common, 21, 22 occurring in nearly 20% of patients, 23 the likelihood that it represents a true hypertensive emergency may be lower than previously thought. 12 By definition, true hypertensive emergencies are an indication for rapid BP lowering. The management of hypertensive emergency is to limit and reverse target organ damage, but not to achieve a "normal" BP. 24 Treatment of a true hypertensive emergency invariably includes intravenous antihypertensive therapy, but in the wrong patient, their use can precipitate adverse events, including acute kidney injury, myocardial infarct, or stroke. A careful balance is therefore required in the management of patients with markedly elevated BP. By recalibrating the expected proportion of patients with elevated BP who have acute target organ damage, our data could help avoid unnecessary and potentially harmful treatment. Unfortunately, the NEDS cannot clarify whether ED visits qualifying as hypertensive emergencies according to our definition resulted in management that included rapid lowering of BP. As this is a hallmark of treatment for true hypertensive emergencies, addition of such data would be highly informative. In the context of our relatively expansive definition with respect to ICD-9 codes, and given that adding treatment criteria would narrow the definition's scope, results of this analysis are more likely to be an upper bound. This supports our overall assertion that hypertensive emergencies are, on the whole, relatively rare in the ED setting. In addition, use of treatment status to define hypertensive emergency for the purpose of estimating incidence would require the assumption that every patient with true hypertensive emergency is indeed treated. An additional potential limitation of this investigation is the definition we used to establish presence of hypertensive emergency. For the purpose of providing a nationwide epidemiological analysis, we defined hypertensive emergency using a combination of ED visit ICD-9 CM codes and patient disposition from the ED. However, the NEDS database is built out of claims data, rather than prospectively collected data designed to address specific research or clinical questions. Thus, the NEDS database does not contain clinical information such as BPs or laboratory values, and some important demographic data including race and ethnicity. That said, in clinical practice it is uncommon to assign a primary or secondary diagnosis of hypertension, malignant or other, absent elevated BP. This makes it more likely that the visits ED indicates emergency department. *Note this row includes ED visits that met all 3 criteria: diagnosis of acute hypertension, admission/death/transfer, and additional diagnosis of target organ damage. we captured did indeed reflect clinically relevant BP elevations. There may also have been patients for whom acute target organ damage was secondary to or associated with elevated BP but hypertension itself was not a coded diagnosis for the visit. Unfortunately, these patients cannot be identified using NEDS data. However, given the link between reimbursement and illness severity in the United States, it is likely that, whenever possible, risk-enhancing variables such as hypertension would be included during the coding process.
In general, hypertensive emergency is an imprecise clinical diagnosis, and this study is fundamentally limited for that reason. Well-defined clinical criteria in a large prospective study would be necessary to make a more precise statement about incidence, though even then there would be important limitations. As an example, diagnosis of papilledema may vary substantially for the same patient between different physicians. There may also be changing coding patterns over time, so that apparent disease prevalence rises despite no fundamental change in patients' clinical status. This may be attributable to, for example, increasing awareness of the diagnosis and incentives to alter coding practices. However, this study was predicated on the assumption that changes in diagnosis codes listed for ED visits truly represent the clinical state of patients, and the Healthcare Cost and Utilization Project data cannot by itself reveal whether or not hypertensive emergencies appear more common because of true changes in disease incidence or because of alterations in coding practice. A prospective study that gathered clinical data for the explicit purpose of defining hypertensive emergency, together with coding data for those same visits, might be able to elucidate how coding practices are evolving over time.
Among the strongest epidemiological studies of hypertensive emergency are 2 recent retrospective analyses using the Nationwide Inpatient Sample, 9,15 a database similar to the NEDS that includes only hospitalized patients. These studies also use ICD-9 codes but do not include explicit requirement for coding that indicated acute target organ damage or other evidence of acuity. In the more recent analysis, Polgreen et al explored the epidemiology of hypertensive emergencies using the following specific ICD-9 codes: malignant hypertension (401.0), hypertensive encephalopathy (437.2), and essential hypertension (401.9). In particular, they found that malignant hypertension and hypertensive encephalopathy made up an increasing proportion of hospitalizations associated with any 1 of these 3 diagnoses but that overall mortality actually decreased slightly. Unlike this work, our study required ICD-9 CM codes to indicate target organ damage. Given existing confusion about the diagnosis, where clinical evidence of acute target organ damage should be the decision point for initiating rapid BP lowering, we feel our approach is more likely to yield a clinically meaningful estimate of the true incidence of hypertensive emergency in the ED. In addition to implications for the ED, these data also have potential bearing on how patients with markedly elevated BP should be approached in non-ED settings, suggesting that referral to the ED for fear of a hypertensive emergency may not be necessary in the vast majority of cases. Indeed, 1 retrospective study found that patients with hypertensive urgency treated in an office setting are not any more or less likely to have a major cardiovascular event compared to patients referred to the ED or hospital. 25 Even among those actually admitted to the hospital, like those patients we defined as hypertensive emergency in the present analysis, charges for ED visits we characterized as hypertensive emergency have risen in the period from 2006 to 2013. Clarifying the epidemiology of hypertensive emergencies in the ED thus has tangible clinical relevance, especially in the context of significant morbidity and mortality in the United States from hypertension-sensitive conditions such as heart disease and stroke. 26 The present study in combination with previous work described above places the balance of evidence in favor of the view that, in absolute terms, hypertensive emergency is rare among ED visits. Even among ED visits with any diagnosis of hypertension (rather than just acute), hypertensive emergency is uncommon. Despite this, hypertension itself remains a major public health problem, contributing substantially to avoidable morbidity and mortality. 13, 14 That we also found patients in the lowest quartile of income to represent the greatest proportion of hypertensive emergency visits is important, mirroring what is known to occur with chronic hypertension. While NEDS does not collect data on chronic hypertension management, these data suggest that long-term challenges with BP control are an important contributor to acute complications. Indeed, in a series of 100 hypertensive emergency cases, 93% were attributed to stopping prescribed medications or patients' inability to access sources of health care. 27 Inadequate outpatient management has been found to be an independent risk factor for markedly elevated BP in a case-control study of Detroit EDs, 28 and this provides 1 potential mechanism that would account for the increased occurrence of hypertensive emergency found among patients with low socioeconomic status. Unfortunately, while these data also show related hospitalizations to be more frequent among blacks, 9 the NEDS database used in this study does not contain race or ethnicity data, so we could not evaluate such subgroups in our study sample.
Conclusions
Based on data from a valid, nationwide, representative sample, the estimated number of visits for hypertensive emergency and the rate per million adult ED visits has more than doubled from 2006 to 2013. However, hypertensive emergencies are rare, occurring in about 2 of every 1000 adult ED visits in the United States, and 6 in 1000 adult ED visits carrying any diagnosis of hypertension. This figure is far lower than what has been sometimes cited in previous literature.
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